Provigil

Drug Teva Pharmaceuticals USA, Inc.
Total Payments
$23,132
Transactions
6
Doctors
1
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2019 $23,132 6 1

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $23,132 6 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
The Nuvigil (Armodafinil) Tablets [C-IV]/Provigil (Modafinil) Tablets [C-IV] Pregnancy Registry Teva Pharmaceuticals USA, Inc. $23,132 1

Top Doctors Receiving Payments for Provigil

Doctor Specialty Location Total Records
Unknown Philadelphia, PA $16,015 3
, MD Gynecology Washington, DC $7,117 3

About Provigil

Provigil is a drug associated with $23,132 in payments to 1 healthcare providers, recorded across 6 transactions in the CMS Open Payments database. The primary manufacturer is Teva Pharmaceuticals USA, Inc..

Payment data is available from 2019 to 2019. In 2019, $23,132 was paid across 6 transactions to 1 doctors.

The most common payment nature for Provigil is "Unspecified" ($23,132, 100.0% of total).

Provigil is associated with 1 research study, including "The Nuvigil (Armodafinil) Tablets [C-IV]/Provigil (Modafinil) Tablets [C-IV] Pregnancy Registry" ($23,132).